Set-up of an in vivo model of facioscapulohumeral muscular dystrophy (FSHD) based on human perivascular cells

Autor: E. Teveroni 1, G. di Blasio 1, 2, S. Maiullari 1, I. Manni 3, F. Maiullari 1, M. Monforte 2, L. Proietti 2, C. Gargioli 4, R. Rizzi 1, E. Ricci 2, G. Deidda 1, F. Moretti 1, 3

Publikováno v: FSH Society Facioscapulohumeral Muscular Dystrophy [FSHD] 2018 International Research Congress & Research Planning Meetings, Las Vegas, Nevada USA, June 8-9, 2018
info:cnr-pdr/source/autori:E. Teveroni 1, G. di Blasio 1,2, S. Maiullari 1,2, I. Manni 3, F. Maiullari 1, M. Monforte 2, L. Proietti 2, C. Gargioli 4, R. Rizzi 1, E. Ricci 2, G. Deidda 1, F. Moretti 1,3/congresso_nome:FSH Society Facioscapulohumeral Muscular Dystrophy [FSHD] 2018 International Research Congress & Research Planning Meetings/congresso_luogo:Las Vegas, Nevada USA/congresso_data:June 8-9, 2018/anno:2018/pagina_da:/pagina_a:/intervallo_pagine

DUX4, the best candidate gene of FSHD, is specific of human cells with mouse models expressing variant forms of DUX family. Moreover, human and mouse muscle express a different pattern of hormone receptor. To study the muscle regenerative potential o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::c2d2b5ccf3009027b2d69f78652c94bf
http://www.cnr.it/prodotto/i/395759